|

HSV-Tk Clinical Trials

1 actively recruiting trial across 1 location

Also known as: AdV-tk gene therapy, Gene therapy, Herpes simplex virus thymidine kinase

Pipeline

Phase 2: 1

Top Sponsors

  • The Methodist Hospital Research Institute1

Indications

  • High Risk Prostate Cancer1
  • Prostate Cancer1
  • Cancer1

Houston, Texas1 trial

Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery

Houston Methodist Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.